Why the study?
Does combined progressive resistance training and a weight-loss diet improve cardiovascular risk factors and circulating adiponectin in obese women?
Does combined progressive resistance training and a weight-loss diet improve cardiovascular risk factors and circulating adiponectin in obese women?
In obese women, combining resistance training with a weight-loss diet improves cardiovascular risk factors such as insulin sensitivity and LDL-C, despite a paradoxical decrease in circulating adiponectin.
Supports combined diet and resistance training to improve insulin sensitivity and LDL-C in obese women; challenges adiponectin elevation as necessary for cardiometabolic benefit.
Increased circulating adiponectin and insulin sensitivity are usually observed after body fat loss induced by a weight-loss diet. Progressive resistance training (PRT) without a concomitant weight-loss diet significantly decreases visceral fat, thus improving insulin sensitivity. Therefore, the purpose of this study was to ascertain the effects of combined 16-week PRT and weight-loss diet on circulating adiponectin and insulin sensitivity index. Thirty-four obese (BMI: 30-40 kg/m(2)) women, aged 40-60 year, were randomized to three groups: a control group (C; n = 9); a diet group (WL; n = 12) with a caloric restriction of 500 kcal/d; and a diet plus resistance training group (WL+RT; n = 13) with the same caloric restriction as group WL and a 16-week supervised whole body PRT of two sessions/week. Both WL and WL+RT groups showed similar decreases in body mass (-6.3% and -7.7%) and visceral fat (-19.9% and -20.5%). WL resulted in an expected increase in circulating levels of adiponectin (P = 0.07) and insulin sensitivity. However, circulating total adiponectin decreased (P < 0.05) in WL+RT group, whereas an improvement in different cardiovascular risk factors (insulin sensitivity, low-density lipoprotein cholesterol (LDL-C), etc.) was observed. In conclusion, in obese women a 16-week combined PRT and weight-loss diet is accompanied by significant improvements in different cardiovascular risk factors in spite of a significant decrease of circulating adiponectin.
No takes yet. Share an insight, caveat, or question.
Ibáñez et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: